Key Market Indicators
Slovak Beta Blocking Medicine Sales are expected to reach $34.15 million by 2026, up from $30.25 million in 2021. This would represent an increase of 2.2% year-on-year. Since 2001, the Slovak market has grown at an annual rate of 4.6%. In 2021, the country ranked 15th, with Chile in the lead at $30.25 million. Italy, Canada and Australia followed, in that order, at numbers 2, 3 and 4.
